Literature DB >> 32265210

Grade I meningioma with disseminated bone disease: a rare clinical phenomenon.

Oriol Mirallas1, David Marmolejo2, Augusto Valdivia2, Maria Vieito2.   

Abstract

Meningioma, the second most common primary tumour of the central nervous system, is classified into three different grades based on their characteristics. Each tumour grade includes different molecular subtype, growth potential, and thus, different prognosis. Grade I meningioma is the most common subtype with a benign course, in which systemic dissemination rarely occurs. We present the case of a 48-year-old male patient with a history of grade I meningioma who was referred 3 years after the initial diagnosis to our centre due to pelvic pain. Computed tomography (CT) images showed new pelvic bone lesions whose histopathological report was compatible with a grade I meningioma. Neither hormonal therapy concomitant with octreotide nor hydroxiurea treatments were effective. Very little is known about this entity's prevalence and treatment when disseminated disease occurs. Thus, we think it is important to increase the positive and negative clinical experiences in this setting. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  CNS cancer; cancer - see oncology; neurooncology; neurosurgery; radiotherapy

Mesh:

Substances:

Year:  2020        PMID: 32265210      PMCID: PMC7244284          DOI: 10.1136/bcr-2019-233708

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Non-resectable slow-growing meningiomas treated by hydroxyurea.

Authors:  David Loven; Ruth Hardoff; Zvi Bar Sever; Adam P Steinmetz; Michael Gornish; Zvi H Rappaport; Eyal Fenig; Zvi Ram; Aaron Sulkes
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

2.  Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Authors:  Ian F Dunn; Ziming Du; Sandro Santagata; David A Reardon; Mehdi Touat; Michael B Sisti; Patrick Y Wen; Renato Umeton; Adrian M Dubuc; Matthew Ducar; Peter D Canoll; Eric Severson; Julia A Elvin; Shakti H Ramkissoon; Jia-Ren Lin; Lais Cabrera; Brenda Acevedo; Peter K Sorger; Keith L Ligon
Journal:  JCO Precis Oncol       Date:  2018-11-27

3.  Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.

Authors:  H B Newton; S R Scott; C Volpi
Journal:  Br J Neurosurg       Date:  2004-10       Impact factor: 1.596

4.  Meningioma metastases: incidence and proposed screening paradigm.

Authors:  Cecilia L Dalle Ore; Stephen T Magill; Adam J Yen; Maryam N Shahin; David S Lee; Calixto-Hope G Lucas; William C Chen; Jennifer A Viner; Manish K Aghi; Philip V Theodosopoulos; David R Raleigh; Javier E Villanueva-Meyer; Michael W McDermott
Journal:  J Neurosurg       Date:  2019-04-05       Impact factor: 5.115

5.  Recurrent intracranial meningioma with multiple pulmonary metastases: A case report.

Authors:  Ke-DA Wang; Yi-Bing Su; Yan Zhang
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

6.  Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.

Authors:  Tareq A Juratli; Christian Thiede; Mara V A Koerner; Shilpa S Tummala; Dirk Daubner; Ganesh M Shankar; Erik A Williams; Maria Martinez-Lage; Silke Soucek; Katja Robel; Tristan Penson; Mechthild Krause; Steffen Appold; Matthias Meinhardt; Thomas Pinzer; Julie J Miller; Dietmar Krex; Heather A Ely; Ian M Silverman; Jason Christiansen; Gabriele Schackert; Hiroaki Wakimoto; Matthias Kirsch; Priscilla K Brastianos; Daniel P Cahill
Journal:  Oncotarget       Date:  2017-11-24

7.  Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.

Authors:  Rami A El Shafie; Maja Czech; Kerstin A Kessel; Daniel Habermehl; Dorothea Weber; Stefan Rieken; Nina Bougatf; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2018-05-08       Impact factor: 3.481

8.  WHO Grade I Meningioma Metastasis to the Lung 26 Years after Initial Surgery: A Case Report and Literature Review.

Authors:  Toshiyuki Enomoto; Mikiko Aoki; Yuki Kouzaki; Hiroshi Abe; Naoko Imamura; Akinori Iwasaki; Tooru Inoue; Kazuki Nabeshima
Journal:  NMC Case Rep J       Date:  2019-09-12

9.  Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature.

Authors:  Bryce D Beutler; Emilie T Nguyen; Rex A Parker; Clement Tran; Jay Acharya; Fernando A Torres; Nageshwara Gullapalli
Journal:  Radiol Case Rep       Date:  2019-11-15

Review 10.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.